VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. [electronic resource]
Producer: 20050217Description: 744-50 p. digitalISSN:- 0013-7227
- Adipocytes -- drug effects
- Animals
- Cyclic AMP-Dependent Protein Kinase Type II
- Cyclic AMP-Dependent Protein Kinases -- metabolism
- Gene Expression
- Lipolysis -- drug effects
- Male
- Nerve Growth Factors -- metabolism
- Neuropeptides -- metabolism
- Neurotransmitter Agents -- metabolism
- Peptide Fragments -- pharmacology
- Pituitary Adenylate Cyclase-Activating Polypeptide
- Rats
- Rats, Sprague-Dawley
- Receptors, Cell Surface -- antagonists & inhibitors
- Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide
- Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
- Receptors, Vasoactive Intestinal Peptide -- agonists
- Receptors, Vasoactive Intestinal Peptide, Type II
- Receptors, Vasoactive Intestinal Polypeptide, Type I
- Vasoactive Intestinal Peptide -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.